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The differentiation of naive CD4+ T cells into lineages with distinct effector functions has been considered to
be an irreversible event. T helper type 1 (Th1) cells stably express IFN-g, whereas Th2 cells express IL-4. The
discovery and investigation of two other CD4+ T cell subsets, induced regulatory T (iTreg) cells and Th17 cells,
has led to a rethinking of the notion that helper T cell subsets represent irreversibly differentiated endpoints.
Accumulating evidence suggests that CD4+ T cells, particularly iTreg and Th17 cells, are more plastic than
previously appreciated. It appears that expression of Foxp3 by iTreg cells or IL-17 by Th17 cells may not
be stable and that there is a great degree of flexibility in their differentiation options. Here, we will discuss
recent findings that demonstrate the plasticity of CD4+ T cell differentiation and the biological implications
of this flexibility.Introduction
Host detection of infectious microbes triggers a chain of events
that results in recruitment and differentiation of T lymphocytes
with functions suited to contain the offending organism. The
initial effector T cell response is often followed by a shift to regu-
latory T (Treg) cells needed to limit potential collateral tissue
damage. The appropriate balance of effector and Treg cells
can be achieved by influx of predifferentiated T cells, by local
induction of distinct effector and/or regulatory T cell profiles, or
by redirection of the differentiation program of the T cells, which
requires plasticity in the regulation of transcriptional targets. The
latter process, only recently appreciated to have a substantial
contribution in vivo, may provide the host with the flexibility to
shift resources, as appropriate, toward the clearance of specific
microbes. In this overview, we will discuss some of the recent
findings suggesting that CD4+ T cells often have the capacity
to redirect their functional programs, thus affecting the balance
between regulatory T cells and cytokine-producing effector
T cells and the cytokine profile of the effector cells.
The T Helper Cell Subset Paradigm
Efficient host defense against invading pathogenic microorgan-
isms is achieved through coordination of complex signaling
networks that link the innate and adaptive immune systems.
Upon interaction with cognate antigen presented by antigen-
presenting cells such as dendritic cells (DCs), CD4+ T cells can
differentiate into a variety of effector subsets, including classical
Th1 cells and Th2 cells, the more recently defined Th17 cells,
follicular helper T (Tfh) cells, and induced regulatory T (iTreg)
cells. The differentiation decision is governed predominantly by
the cytokines in the microenvironment and, to some extent, by
the strength of the interaction of the T cell antigen receptor
with antigen (Boyton and Altmann, 2002). Th1 cells are charac-
terized by their production of IFN-g and are involved in cellular
immunity against intracellular microorganisms. IL-12 produced
by innate immune cells as well as IFN-g produced by both NK
cells and T cells polarize cells toward the Th1 cell differentiation
program through action of the signal transducer and activator of646 Immunity 30, May 22, 2009 ª2009 Elsevier Inc.transcription 4 (Stat4), Stat1, and T box transcription factor
T-bet. Th2 cells produce IL-4, IL-5, and IL-13 and are required
for humoral immunity to control helminths and other extracellular
pathogens. Th2 cell differentiation requires the action of GATA3
downstream of IL-4 and Stat6. Th17 cells produce IL-17A (here-
after referred to as IL-17), IL-17F, and IL-22 and play important
roles in clearance of extracellular bacteria and fungi, especially
at mucosal surfaces. Th17 cell differentiation requires retinoid-
related orphan receptor (ROR)gt, a transcription factor that is
induced by TGF-b in combination with the proinflammatory cyto-
kines IL-6, IL-21, and IL-23, all of which activate Stat3 phosphor-
ylation (Chen et al., 2007). Tfh cells are a subset of helper T cells
that regulate thematuration of B cell responses. Differentiation of
these cells requires the cytokine IL-21 (Vogelzang et al., 2008;
Nurieva et al., 2008) and may be dependent on the transcription
factor Bcl-6 (Fazilleau et al., 2009).
Tight regulationof effector T cell responses is required for effec-
tivecontrol of infectionsandavoidanceof autoimmuneand immu-
nopathological diseases. Aberrant Th1 and Th17 cell responses
play critical roles in organ-specific autoimmunity, whereas Th2
cells are culprits in allergy and asthma. Treg cells have essential
roles in maintenance of immune homeostasis, regulating these
effector T cell responses and thus preventing their potentially
pathogenic effects through a variety of mechanisms (Vignali
et al., 2008; Shevach, 2009, this issue of Immunity). Treg cells
are characterized by the expression of the forkhead transcription
factor Foxp3. Foxp3 plays a critical role in specifying and main-
taining the functional program of Treg cells, but the signals
upstream of Foxp3 remain unclear (Hori et al., 2003; Fontenot
et al., 2003; Khattri et al., 2003; Fontenot et al., 2005). Two major
categories of Foxp3+ Treg cells have been identified: the naturally
occurring CD4+ CD25+ Treg (nTreg) cells that arise in the thymus
and the TGF-b-induced iTreg cells produced in the periphery
(Curotto de Lafaille and Lafaille, 2009; Josefowicz andRudensky,
2009, both in this issue).Both typesofTregcellsmayparticipate in
maintenanceof peripheral toleranceandpreventionof autoimmu-
nity, although their individual contributions have not yet been
closely examined in vivo (Chen et al., 2003).
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Th2 cell immune responses because mice lacking them exhibit
overwhelming autoimmune disease characterized by excessive
production of Th1 and Th2 cell cytokines (Kanangat et al.,
1996; Kim et al., 2007). Whether Treg cells also suppress Th17
cell responses is less clear. One potential piece of evidence
comes from mice that lack microRNA processing from the
CD4+CD8+ stage onward in T cell development. In these mice,
spontaneous differentiation of Th1 and Th17 cells occurs and
is associated with the loss of Treg cell function (Chong et al.,
2008). However, it has become apparent that the differentiation
of Th17 cells may actually be linked to the differentiation of iTreg
cells (Zhou et al., 2008a). The differentiation of both iTreg and
Th17 cells requires TGF-b. In response to TCR stimulation in
the presence of TGF-b, naive CD4+ T cells can differentiate
into either Th17 or iTreg cells depending on the overall cytokine
milieu. The balance between Th17 cells and Treg cells may be
influenced by the ability of nTreg cells to produce TGF-b, which,
in the presence of proinflammatory cytokines, can induce naive
CD4+ T cells to differentiate into Th17 cells (Veldhoen et al.,
2006a).
Commitment of CD4+ T cells to distinct effector lineages in the
course of cytokine polarization and multiple rounds of stimula-
tion was proposed to involve stable programs of gene expres-
sion that correlate with epigenetic changes at loci encoding
cytokine genes (Murphy et al., 1996; Bird et al., 1998; Ansel
et al., 2003). As a result, cells maintain distinct cytokine profiles
even in conditions that promote other effector lineages (Murphy
et al., 1996). This view has undergone considerable re-evaluation
in the wake of recent findings based on closer scrutiny of Th17
and Treg cell differentiation and function. The role of plasticity
in CD4+ T cell differentiation will be discussed in the sections
that follow.
Relationship between Th17 and Th1-Th2 Cells
The notion that effector T helper cell subsets represent distinct
terminally differentiated lineages has been favored on the basis
of a series of in vitro experiments demonstrating that, once naive
cells have been polarized into Th1 or Th2 cells, these phenotypes
could not be reversed even when transferred into new polarizing
conditions (Murphy et al., 1996). In addition, under polarizing
conditions, stable cytokine production was observed only after
a set number of cell divisions; such a result could be interpreted
as a requirement for establishment of a stable transcriptional
program (Bird et al., 1998; Grogan et al., 2001). The requirement
for specific ‘‘master regulator’’ transcription factors, T-bet and
GATA3 for differentiation of Th1 and Th2 cells, respectively, has
also reinforced the lineage model. Crossregulation during Th1-
Th2 cell differentiation has been demonstrated in numerous
studies. For example, the commitment to the Th1 cell lineage is
associated with the expression of the b2 chain of the IL-12R
complex, thus conferring IL-12 responsiveness. IL-12Rb2 induc-
tion is dependent on T-bet activation through IFN-g and Stat1
signaling (Mullen et al., 2001; Afkarian et al., 2002). The Th2 cell
cytokine IL-4 appears to repress IL-12 signaling through inhibi-
tion of IL-12Rb2 expression, thus antagonizing Th1 cell differen-
tiation (Szaboet al., 1997).Conversely, Th1cell cytokines repress
Th2 cell differentiation through a feed-forwardmechanism. IFN-g
induces T-bet, which in turn induces Runx3 expression. Runx3then cooperates with T-bet to further promote IFN-g production
while silencing the Il4 gene in Th1 cells by binding to the Ifng
promoter and the Il4 silencer, respectively (Djuretic et al., 2007;
Naoe et al., 2007). These data have led to the notion that Th1
and Th2 cells constitute stable terminally differentiated lineages.
RORgt is the T cell-subset-specific transcription factor
required for Th17 cell differentiation and is both necessary and
sufficient for induction of IL-17 and other genes whose expres-
sion characterizes the Th17 effector cell subset. Crossregulation
similar to that between Th1 and Th2 cells may also occur
between Th17 and Th1 or Th2 cells. IFN-g and IL-4 both inhibit
induction of IL-17 (Harrington et al., 2005). Additionally, IL-27,
a member of the heterodimeric IL-12 cytokine family, promotes
Th1 cell differentiation by inducing T-bet and IL-12Rb2 (Takeda
et al., 2003; Lucas et al., 2003) and concurrently inhibits Th17
cell differentiation in a Stat1-dependent manner (Batten et al.,
2006; Stumhofer et al., 2006). The genetic loss of T-bet strongly
favors IL-17 expression both in CD4+ and CD8+ T cells (Harring-
ton et al., 2005; Park et al., 2005; Mathur et al., 2006; Yang et al.,
2008c; Intlekofer et al., 2008). Likewise, Growth factor indepen-
dent 1 (Gfi-1) induced by IL-4 supports optimal Th2 cell differen-
tiation (Zhu et al., 2002) and inhibits differentiation of either Th17
or iTreg cells (Zhu et al., 2009). Normally, Th2 cells are unable to
express IL-17when subjected to Th17 cell-polarizing conditions.
However, Gfi-1 deficiency in Th2 cells leads to expression of
IL-17, suggesting that Gfi-1 may play a crucial role in repressing
IL-17 expression (Zhu et al., 2009). Thus it appears that Th1 and
Th2 cell signals are potent inhibitors of Th17 cell differentiation.
However, whether the converse occurs, i.e., inhibition of Th1 and
Th2 cell differentiation by Th17 cell signals, remains to be deter-
mined. These findings have reinforced the notion that Th17 cells
represent a unique T helper cell lineage different from Th1 or Th2
cells (Ivanov et al., 2006). The stability of the Th17 cell pheno-
type, once it is established, will be discussed further below.
Relationship between Th17 and iTreg Cells
TGF-b is profoundly important for establishment of immunolog-
ical tolerance, at least in part because it is required for the differ-
entiation of iTreg cells and for maintenance of nTreg cells after
they emigrate from the thymus (Chen et al., 2003; Li et al.,
2006;Marie et al., 2005). For this reason, it was surprising to learn
that TGF-b is also essential for the differentiation of proinflamma-
tory Th17 cells (Bettelli et al., 2006;Mangan et al., 2006; Veldhoen
et al., 2006a). Mice lacking TGF-b lack both Foxp3+ Treg and
Th17 cells and have overwhelming autoimmunity largely caused
by uncontrolled Th1 cell activity (Li et al., 2006; Veldhoen et al.,
2006b). These findings suggest an intimate link between the
Treg and Th17 cell programs of differentiation, and indeed there
is evidence for such a relationship from both in vitro and in vivo
studies (Bettelli et al., 2006; Zhou et al., 2008a; Yang et al.,
2008a; Koenen et al., 2008; Beriou et al., 2009). Exposure of
antigen-activated naive CD4+ T cells to TGF-b results in tran-
scriptional upregulation of both Foxp3 and RORgt+, transcription
factors that direct distinct CD4+ T cell differentiation programs
(Zhou et al., 2008a). T cells that coexpress RORgt and Foxp3
have been identified in vivo in both mice and humans (Zhou
et al., 2008a; Vooet al., 2009). Foxp3+RORgt+ cells from the small
intestine produce less IL-17 compared to Foxp3RORgt+ cells
(Zhouetal., 2008a),whereasFoxp3deficiency results in amarked
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These observations suggest that Foxp3 may antagonize
RORgt-induced IL-17 expression in a cell-intrinsic manner. The
Foxp3+RORgt+ cells may also exist as a transient population
that can give rise to either Treg or Th17 cells (Zhou et al., 2008a).
A plausible explanation for the reduced amount of IL-17 in cells
that coexpress RORgt and Foxp3 is provided by the finding that
these two transcription factors can interact with each other,
perhaps in the context of larger nuclear complexes. A similar
physical interaction was first demonstrated between Foxp3 and
RORa, which is closely related to RORgt and is similarly sufficient
for inducing IL-17 expression but has only aminor redundant role
in Th17 cell differentiation (Du et al., 2008; Yang et al., 2008b; L.Z.
and D.R.L., unpublished data). Whereas transduction of naive
CD4+ T cells with RORgt induces IL-17 expression, cotransduc-
tionwith Foxp3 abrogates induction as long as Foxp3 contains its
exon-2-encoded domain that is required for binding to RORgt
(Zhou et al., 2008a). After in vitro induction of RORgt and Foxp3
by TGF-b, cells do not express IL-17 but have the dual potential
to differentiate into either the Th17 or Treg cell lineage depending
on the cytokine environment. In the presence of proinflammatory
cytokines (IL-6, IL-21, or IL-23) and low concentrations of TGF-b,
RORgt expression is further upregulated,whereasFoxp3expres-
sion and function are inhibited. This relieves repression of RORgt
activity by Foxp3 in favor of Th17 cell lineage specification. In
contrast, in the absence of proinflammatory cytokines, high
concentrations of TGF-b are optimal for Foxp3 expression and
thus tip the balance toward Treg cell differentiation (Zhou et al.,
2008a). This shift toward Treg cells is enhanced by IL-2 and reti-
noic acid (RA). Both inhibit Th17 cell differentiation by reducing
RORgt expression andenhancing TGF-b-inducedFoxp3expres-
sion, thus influencing Th17-Treg cell specification (Laurence
et al., 2007; Sun et al., 2007; Coombes et al., 2007; Mucida
et al., 2007).
Even though Foxp3 inhibits expression of IL-17, Foxp3+IL-17+
CD4+ T cells have been observed both in vitro, after polarization
in the presence of TGF-b and IL-6, and in vivo in mice and
humans (Voo et al., 2009; Yang et al., 2008a; Zhou et al., 2008a).
Circulating human Foxp3+IL-17+ T cells have in vitro suppressive
activity (Beriou et al., 2009; Voo et al., 2009), but it is not yet
known whether they have the functions of conventional Th17
cells. Signals from proinflammatory cytokines appear to prevent
Foxp3-mediated inhibition of RORgt activity (Zhou et al., 2008a),
but may spare the regulatory activity of Treg cells.
Several transcription factors have been implicated in modu-
lating the RORgt-Foxp3 balance during T helper cell differentia-
tion. IRF4 is essential for Th17 cell differentiation both in vitro
and in vivo (Brustle et al., 2007). Its absence in mice resulted in
reduced RORgt expression, increased Foxp3 expression, loss
of IL-17 production, and protection from experimental autoim-
mune encephalomyelitis (EAE). Irf4was also identified as a direct
target of Foxp3, and its selective loss in Treg cells selectively
impaired suppression of Th2 cell responses (Zheng et al.,
2009). Runx1 was recently shown to form a complex with RORgt
and to cooperate with it to promote Th17 cell differentiation
(Zhang et al., 2008). In Treg cells, an interaction between Runx1
and Foxp3 was reported to be required for suppression of IL-2
and IFN-gproduction, upregulation of Tregcell-associatedmole-
cules, and suppressive activity (Ono et al., 2007). Runx1 is also648 Immunity 30, May 22, 2009 ª2009 Elsevier Inc.required for maintaining Foxp3 expression in nTreg cells and in
TGF-b-induced iTreg cells (M.M.W.C. and D.R.L., unpublished
data). Thus, functional plasticity in cells that coexpress RORgt
and Foxp3 may be governed by the ability of Runx to cooperate
with either transcription factor.
Stat3, a transcription factor common to the IL-6, IL-21, and
IL-23 signaling pathways, is also essential for Th17 cell differen-
tiation. Stat3 binds to the Il17 locus to direct its transcription,
presumably through cooperative activity with RORgt (Chen
et al., 2006). TGF-b-induced Foxp3 expression is inhibited
by proinflammatory cytokines in a Stat3-dependent manner.
Forced expression of an active form of Stat3 enhanced IL-17
expression in the presence of TGF-b, presumably by upregula-
tion of RORgt expression and suppression of Foxp3 expression
(Zhou et al., 2007; Yang et al., 2007). It remains to be determined
whether the coordinated activity of Stat3 and RORgt in induction
of IL-17 is due to a physical interaction between these two
factors and whether relief of Foxp3 inhibition by proinflammatory
cytokines is mediated by perturbation of RORgt-Foxp3 interac-
tion through the activity of Stat3.
Flexibility in the Differentiation of Foxp3+ Cells
During the past two years, there have been multiple reports indi-
cating that the differentiation program of Foxp3+ Treg cells is not
fixed. A series of in vitro studies and in vivo analyses of the intes-
tine have shown that Treg cells have the propensity to differen-
tiate into Th17 or Tfh cells. TCR-stimulated thymus-derived
Foxp3+ cells, which produce TGF-b, were shown to produce
IL-17 after exposure to IL-6 (Xu et al., 2007). In contrast, culturing
of the cells in Th1 cell polarization conditions did not alter their
phenotype. By genetic fate mapping, using Foxp3-Cre mice to
mark cells that expressed Foxp3 at some stage of development,
at least one-quarter of small intestinal Th17 cells were found to
have expressed Foxp3 during their ontogeny (Zhou et al.,
2008a). It is unclear why some IL-17+ cells but not others
expressed Foxp3 during their differentiation. There may be
stochastic activation of Foxp3 during the establishment of
the Th17 cell program or, alternatively, Foxp3 expression may
mark a distinct differentiation pathway. It remains to be deter-
mined whether there are functional differences between Th17
cells that differentiated in the presence or absence of Foxp3
expression.
It has been suggested that IL-6, produced by antigen-present-
ing cells as a result of Toll-like receptor engagement, blocks
CD4+CD25+ Treg cell-suppressive activity (Pasare and Medzhi-
tov, 2003). Another possible explanation is that IL-6 may convert
Treg cells into proinflammatory cells. Indeed, it was recently
reported that Treg cells can be converted to IL-17-expressing
cells in a proinflammatory cytokine environment (Yang et al.,
2008a; Osorio et al., 2008), but one study suggests that, unlike
nTreg cells, iTreg cells induced by TGF-b and IL-2 are resistant
to Th17 conversion by IL-6 (Zheng et al., 2008). It is unclear
whether these discrepancies are due to in vitro phenomena. No
evidence has been found for the reciprocal conversion of Treg
cells from IL-17-expressing cells, consistent with a lack of active
epigeneticmodifications at theFoxp3 locus in differentiated Th17
cells (discussed below) (Croxford et al., 2009; Wei et al., 2009).
The physiological relevance of Treg cell conversion into Th17
cells has been unclear. Interestingly, conversion of Foxp3+ Treg
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dendritic cells selectively activated by dectin-1, a C-type lectin
receptor involved in fungal recognition (Osorio et al., 2008).
Fungal infections have been linked to IL-17 responses (Lei-
bundGut-Landmann et al., 2007). Thus, conversion of Treg cells
into Th17 cells may help restrain infections with specific fungal
pathogens such as Candida albicans. Treg cells were unexpect-
edly found to have a critical role in host protection from mucosal
infection with Herpes simplex virus (Lund et al., 2008). The ability
of Treg cells to be converted into effector cells in vivo may there-
fore also contribute to host protection after infection with viruses
and other microbial pathogens.
Redifferentiation of Treg cells into effector T helper cells other
than Th17 cells has also been reported. Although a fraction of
highly purified nTreg cells can express IFN-g and T-bet and
maintain Foxp3 expression after culture in Th1 cell polarizing
conditions (Wei et al., 2009), there is still no consensus on the
ability of Treg cells to undergo this change of phenotype (Xu
et al., 2007). It is unclear whether the Foxp3+IFN-g+ cells retain
suppressive activity. One setting in which Foxp3-expressing
cells have clearly converted into Th1 or Th2 cell-phenotype
cells is in mice with Treg cell-specific deletion of the RNaseIII
enzyme Dicer that is required for microRNA biogenesis (Zhou
et al., 2008b). In conditional Dicer-Foxp3-cre mice, genetic
fate-mapping demonstrated that a substantial number of IL-4-
and IFN-g-expressing cells had differentiated from cells that
previously had expressed Foxp3. Similarly, in mice that lacked
Drosha, another RNaseIII enzyme required for microRNA bio-
genesis, in all T cells, there was spontaneous differentiation of
Th1 and Th17 cell-phenotype cells, although it was not deter-
mined whether this was a result of Treg cell conversion (Chong
et al., 2008). Thus, it appears that microRNAs may be required
in Treg cells to provide stability and prevent conversion (Lu
et al., 2009).
Foxp3+ Treg cells as well as Th17 cells are most abundant at
mucosal barriers. Specific commensal microbiota are required
for differentiation or migration of Th17 cells to gut lamina propria
(Ivanov et al., 2008), and thesepotentially inflammatory Tcells are
thought to be held in check by the local Treg cells. In light of their
plasticity, Treg cells may also convert into inflammatory-cyto-
kine-producing cells, especially in disease conditions. In the
gut, commensal bacteria stimulate DCs to produce large quanti-
ties of proinflammatory cytokines through purinergic receptors
or Toll-like receptors (Atarashi et al., 2008; Hall et al., 2008). It
is conceivable that these proinflammatory cytokines might
promote conversion of Treg cells into inflammatory effector
T cells that could cause harmful inflammation. However, this is
not the case, at least in the context of normal exposure to
commensal flora. For example, the symbiontBacteroides fragilis,
via production of polysaccharide A (PSA), influences immune
homeostasis and protects animals from experimental colitis by
inhibiting Th17 cell differentiation and inducing IL-10 production
(Mazmanian et al., 2005; Mazmanian et al., 2008). In addition,
several recent studies have implicated RA-producing CD103+
DC in the gut as inducers of Foxp3 expression (Mucida et al.,
2007; Coombes et al., 2007; Sun et al., 2007). RA increased the
proportion of Foxp3+ cells induced by TGF-b in vitro and stabi-
lized Foxp3 expression in vivo even upon adoptive transfer and
under inflammatory conditions (Benson et al., 2007). In the gut,RA may thus play a role in stabilizing or reinforcing the Treg cell
program, preventing microbiota-induced inflammation.
Most recently, Fagarasan and colleagues showed that Foxp3+
Treg cells in Peyer’s patches differentiate into Tfh cells, which
then participate in germinal center formation and IgA synthesis
in the gut. The differentiation of Foxp3+ Treg cells into Tfh cells
required the loss of Foxp3 expression and interaction with B cells
through CD40 (Tsuji et al., 2009). Remarkably, only the Foxp3+
T cell fraction had the capacity to give rise to Tfh cells, at least
in the intestine. It is not yet known whether nTreg, iTreg cells,
or both are precursors for these specialized T cells. Rudensky
and colleagues recently showed that inactivation of IRF4 specif-
ically in Foxp3+ cells resulted in elevated Th2 cytokine produc-
tion and enhanced formation of germinal centers (Zheng et al.,
2009). Although differentiation of Tfh cells was not examined in
that study, it is possible that increased Tfh cells could lead to
those phenotypes. Consistent with this, it was recently shown
that Tfh cells can be differentiated from IL-4+ Th2 cells in
response to helminth antigens (King and Mohrs, 2009; Zaretsky
et al., 2009). It is possible that IRF4 is involved in restraining
reprogramming of Treg cells toward the Tfh effector cell fate.
Taken together, the recent results suggest that the local
microenvironment, through provision of specific cytokines and/
or cell-cell (or cell-microorganism) interactions, directs multiple
possible alternate fates that Foxp3+ cells can adopt (Figure 1).
In light of these findings, it will be important to consider potential
complications for the therapeutic use of Treg cells in autoim-
mune diseases and organ transplantation. Treg cell therapy
may thus be less beneficial or even harmful in established inflam-
matory conditions because their transfer into an established
inflammatory lesion could lead to their reprogramming. It may
be safer to administer Treg cells before disease onset or organ
transplantation because the amounts of proinflammatory cyto-
kines are expected to be low. Suppression of inflammatory cyto-
kines (e.g., IL-6, IL-23, or IL-12) may also be required to prevent
redifferentiation of Treg cells into cells with pathogenic potential
(e.g., Th17 or Th1 cells).
Instability of the Th17 Cell Program
The notion that Th17 cells are derived from the Th1 cell lineage
was discarded by the findings that these cells express RORgt
and can develop in the absence of T-bet or Stat4 (Ivanov et al.,
2006; Weaver et al., 2007). However, under homeostatic or
inflammatory conditions, IL-17+IFN-g+ double-producer cells
are easily detected, suggesting that there may be some intricate
relationship between the Th1 and Th17 cell differentiation
programs. Indeed, several recent findings highlight the plasticity
of Th17 cells (Figure 1). In vitro-generated Th17 cells lose IL-17
and IL-17F expression without constant exposure to IL-6 and
TGF-b (Lexberg et al., 2008). Cells polarized in Th17 cell condi-
tions for as long as 3 weeks still failed to maintain IL-17 and
IL-17F expression and were converted to Th1 or Th2 cells in the
presence of IL-12 or IL-4, respectively (Lexberg et al., 2008;
Lee et al., 2009). Such cells also lost IL-17 expression and
expressed IFN-g in the presence IL-23, but this required Stat4,
suggesting some partial signaling through the IL-12 receptor
machinery. The presence of TGF-b alone was shown to sustain
expression of IL-17 and IL-17F (Lee et al., 2009). However, it is
worth noting that Th17 cells secrete IL-21, which may functionImmunity 30, May 22, 2009 ª2009 Elsevier Inc. 649
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autocrinemanner. In contrast to in vitro-differentiated Th17 cells,
in vivomemoryCD4+CD62Llo Th17 cells appearmore resistant to
conversion (Lexberget al., 2008). Thus, these results suggest that
theremay be epigenetic differences between in vitro- and in vivo-
generated Th17 cells (discussed below).
Th17 cells (expressing an IL-17F-Thy1.1 transgene) are active
in inducing colitis upon transfer into immunodeficient mice, but
many of these cells convert to Th1 cells (Lee et al., 2009). Consis-
tent with this, diabetogenic BDC2.5 CD4+ T cells polarized
in vitro to the Th17 cell phenotype lose IL-17 expression and
express IFN-g after adoptive transfer into NOD-SCID mice, ulti-
mately causing b-cell destruction and diabetes (Bending et al.,
2009). It will be important to determine whether passage through
a Th17 cell stage of differentiation is important for the develop-
ment of pathogenic Th1 cells in these and other disease models.
It is also worthwhile to mention that the above in vivo studies
involved transferring cells to lymphopenic hosts in which homeo-
static proliferation may influence the plasticity of T helper cell
differentiation.
Figure 1. TheCytokineMilieu Determines CD4+ TCell Differentiation
and Conversion
Upon encountering foreign antigens presented by antigen-presenting cells,
naive CD4+ T cells can differentiate into Th1, Th2, Th17, iTreg, and Tfh cells.
These differentiation programs are controlled by cytokines produced by innate
immune cells, such as IL-12 and IFN-g, which are important for Th1 cell differ-
entiation, and IL-4, which is crucial for Th2 cell differentiation. TGF-b together
with IL-6 induces Th17 cell differentiation, whereas iTreg differentiation is
induced by TGF-b, retinoic acid (RA), and IL-2. Tfh cell differentiation requires
IL-21. Specific transcription factors that orchestrate thedifferentiationprogram
of each T helper cell subset have been identified: T-bet for Th1 cells, GATA3 for
Th2 cells, RORgt for Th17 cells, and Foxp3 for iTreg cells. The effector T cells
had been thought to be terminally differentiated lineages, but it now appears
that there is considerable plasticity allowing for conversion to other pheno-
types. Although Th1 and Th2 cells display more stable phenotypes, iTreg cells
and Th17 cells can readily switch to other T helper cell programs under certain
cytokine conditions. For example, iTregs can become IL-17-producing cells
upon stimulation of IL-6 and IL-21. Treg cells can also switch to Tfh cells, and
this requires B cells and CD40-CD40L interaction. Th17 cells may also convert
into IFN-g-producing Th1 cells or IL-4-producing Th2 cells when stimulated by
IL-12 or IL-4, respectively. Evidence also suggests that Th2 cells can switch to
IL-9-producing cells in response to TGF-b, although it is unclear whether these
‘‘Th9’’ cells truly represent a distinct lineage.650 Immunity 30, May 22, 2009 ª2009 Elsevier Inc.Although Th17 cells make the signature cytokines IL-17,
IL-17F, and IL-22, they may represent a heterogeneous popula-
tion with dynamic phenotypic and/or functional properties that
are influenced by different environmental cues. For example,
high concentrations of TGF-b can inhibit IL-22 expression,
leading to generation of IL-17+IL-22 cells (Zheng et al., 2007).
Th17 cells polarize in the presence of TGF-b and IL-6, but without
IL-23, they appear to have curtailedpathogenic potential, despite
expression of IL-17. These cells were shown to express IL-10,
a cytokine that restrains inflammatory responses (andhas recently
been shown to be produced by all subsets of CD4+ T cells). In the
presence of IL-23, ‘‘protective’’ Th17 cells were converted into
‘‘pathogenic’’ Th17 cells that expressed proinflammatory cyto-
kines but not IL-10 (McGeachy et al., 2007). The experiments
described above, using in vitro polarization or adoptive transfer,
are representative of current approaches for studying Th17 cell
stability (Lee et al., 2009; Croxford et al., 2009; Wei et al., 2009;
Bending et al., 2009). However, given our still limited under-
standing of in vitro Th17 cell differentiation, which varies greatly
according to culture conditions (Veldhoen et al., 2009), and the
divergence of transcriptional profiles of Th17 cells generated
in vitro versus those present in vivo (L.Z. and D.R.L., unpublished
data), there needs to be cautious interpretation of results.
The plasticity of Th17 cells has important biological implica-
tions. Th17 cells are abundant in the intestinal lamina propria
of healthy animals. In view of an unstable Th17 cell phenotype,
there is likely selective pressure for maintaining a Th17 cytokine
profile within the gut environment. Commensal bacteria are
essential for induction of Th17 cells that participate in the main-
tenance of epithelial integrity and clearance of extracellular path-
ogens (Atarashi et al., 2008; Hall et al., 2008; Ivanov et al., 2008).
Selective antibiotic treatment inhibited intestinal lamina propria
Th17 cell differentiation in mice (Ivanov et al., 2008; Atarashi
et al., 2008). Accordingly, humans subjected to long-term and
broad-spectrum antibiotic treatment can developCandida infec-
tions, which are normally controlled by Th17 cell responses. Anti-
biotic-induced disruption of the normal intestinal microbiota can
also lead to diarrhea caused by the anaerobic bacterium Clos-
tridium difficile (DuPont et al., 2008), and this may be linked to
an altered Th17-Treg cell balance as a result of clearance of
Th17 cell-inducing commensal bacteria.
Recruitment of neutrophils after activation of Th17 cells results
in clearance of microbes, but can also cause tissue destruction.
Appropriate and timely decline of Th17 cell responses is there-
fore probably required to limit host tissue injury. This may be
achieved by a shift toward production of IL-10 by Th17 cells.
Steady-state Th17 cells may also have the capacity to adjust
their cytokine profiles to combat diverse pathogens as needed.
Thus, together with the de novo-differentiated Th1 cells, rapid
transition from Th17 to Th1 cell responses may represent an effi-
cient local host defense for controlling infections with intracel-
lular microbes.
Epigenetic View of T Helper Cell Differentiation
The differentiation of T helper cells is intricately coupled to epige-
netic changes in chromatin structure, histone and DNAmodifica-
tions, and the expression of small noncoding RNAs (Ansel et al.,
2003; Merkenschlager and Wilson, 2008; Wilson et al., 2009).
Earlier analyses of epigenetic changes during T helper cell
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Reviewdifferentiation have largely focused on the gene loci encoding
cytokines that mark Th1 or Th2 cell lineages, i.e., IFN-g and IL-4,
IL-5, and IL-13, respectively. Recent technological advances,
e.g., chromatin immunoprecipitation (ChIP) followed by genomic
tiling arrays (ChIP-chip) or by high-throughput sequencing
(ChIP-Seq), have allowed genome-wide examination of histone
modifications and DNA methylation that accompany changes
in gene expression in CD4+ T cell subsets. Such analysis has
provided insights into the mechanisms underlying T helper cell
plasticity (Wei et al., 2009). Trimethylation of histone H3 lysine 4
(H3K4me3) is a permissive mark found at the promoters and the
enhancers of active genes, whereas trimethylation of histone
H3 lysine 27 (H3K27me3) is present in broad domains that
encompass inactive genes. H3K4me3 and H3K27me3modifica-
tions are both present at some genomic regions, and these biva-
lent modifications have been suggested to poise genes ready for
either activation or repression during differentiation.
The epigenetic marks found at the Ifng, Il4, and Il17 gene
loci correlated precisely with Th1 and Th2 cell lineages, with
H3K4me3 at the Ifng locus and H3K27me3 at the Il4 and Il17
loci in Th1 cells and H3K4me3 at the Il4 locus and H3K27me3
at the Ifng and Il17 loci in Th2 cells. Intriguingly, the Tbx21 (en-
coding T-bet) and Gata3 genes displayed a bivalent status in
Th2 and Th1 cells, respectively, consistent with a report suggest-
ing that interconversion can occur between Th1 and Th2 cells
under appropriate inflammatory conditions (Krawczyk et al.,
2007). Consistent with the plasticity evident for Treg cells,
Tbx21, Gata3, and Rorc were all bivalently modified in Treg cells
(Figure 2). Such bivalentmodificationsmay allow specific lineage
regulator gene loci to be activated under different polarizing
conditions, thus reprogramming Treg cells into other lineages.
Similarly, in vitro-differentiated Th17 cells displayed bivalent
epigenetic status at the Tbx21 and Gata3 loci, and such a result
suggests that these cells are preconditioned to be redirected
toward Th1 or Th2 cell fates. Such reprogramming appears to
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Figure 2. Epigenetic Status of Lineage-
Specific Transcriptional Regulator Gene
Loci in CD4+ T Cells
Recent findings suggest that T helper cell differen-
tiation is more plastic than previously appreciated.
Each CD4+ T cell subset can adopt alternate cyto-
kine profiles in response to cytokine environmental
changes. Among four subsets of T cells, Treg cells
and Th17 cells display the highest propensity to
switch to other phenotypes. The molecular mech-
anism underlying this plasticity may be related to
poised, bivalent epigenetic states (i.e., permissive
H3K4me3 plus repressive H3K27me3 marks)
at the transcriptional regulator (e.g., T-bet and
Gata3) gene loci. Consistent with permissive
epigenetic marks at Foxp3 and RORgt gene loci,
coexpression of Foxp3 and RORgt occurs in Treg
cells, but RORgt activity is inhibited by Foxp3.
be unidirectional, given that repressive
epigenetic configuration was observed
at both the Il17a and Rorc loci in Th1
and Th2 cells (Wei et al., 2009).
Thymus-derived nTreg cells and
peripherally derived iTreg cells appear to
differ in their propensity for reprogram-
ming. This is reflected in the DNA methylation status of
the Foxp3 locus and in histone marks at the Rorc locus.
H3K27me3 was found at the Il17a locus, whereas H3K4me3
was found at the Rorc locus in iTreg cells, consistent with the
notion that RORgt expression was induced by TGF-b, but
RORgt-directed IL-17 expression was inhibited by Foxp3 (Wei
et al., 2009; Zhou et al., 2008a) (Figure 2). In contrast, in nTreg
cells, bivalent H3K4me3 and H3K27me3 were present at the
Rorc locus, allowing for potential coexpression of Foxp3 and
RORgt.
When nTreg cells were cultured in Th17 or Th1 cell-polarizing
conditions, a substantial fraction of IL-17+Foxp3+ or IFNg+
Foxp3+ cells arose without downregulation of Foxp3 expression
(Xu et al., 2007; Yang et al., 2008a; Wei et al., 2009). In contrast,
TGF-b-induced Treg cells readily lost Foxp3 expression and
acquired IL-17 expression when subjected to Th17 cell-polar-
izing conditions (Yang et al., 2008a). There is accumulating
evidence that the difference in stability of Foxp3 expression
between nTreg cells and iTreg cells is due to epigenetic differ-
ences at the Foxp3 locus (Huehn et al., 2009). Besides the
promoter and an intronic enhancer, a highly conserved CpG-
rich element is present upstream of exon 1 in the Foxp3 locus
and is referred to as the Treg cell-specific demethylated region
(TSDR) (Floess et al., 2007; Kim and Leonard, 2007; Baron
et al., 2007; Nagar et al., 2008). This region is fully demethylated
in nTreg cells but remains methylated in TGF-b-induced Treg
cells and activated human conventional T cells that transiently
express Foxp3. Consistent with this, inhibition of DNA methyla-
tion with azacytidine conferred stability of Foxp3 expression
induced by TGF-b. Intriguingly, azacytidine, even in the absence
of exogenous TGF-b, also promoted de novo induction of Foxp3
expression, most likely through an indirect mechanism, high-
lighting the importance of DNA methylation for the regulation
of Foxp3 transcription (Polansky et al., 2008). Furthermore,
in vivo-derived antigen-specific Treg cells have stable Foxp3Immunity 30, May 22, 2009 ª2009 Elsevier Inc. 651
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TSDR (Polansky et al., 2008). Further studies on regulation of
DNA methylation at the TSDR will probably provide important
insights into plasticity of Treg cell differentiation.
All together, these data on epigenetic modification of histones
and DNA highlight the plasticity of CD4+ T cell differentiation
programs, suggesting that the ‘‘lineage-specific’’ transcription
factors may not necessarily have mutually exclusive expression
patterns. Lineage specification is therefore not only determined
by the epigenetic status of signature cytokine loci but also relies
on the epigenetic states of key transcription factors. With current
technological advances, we should expect in the near future
a comprehensive epigenetic profile of T helper cell lineages,
including the analyses of further histone modifications and of
multiple target gene loci associated with the individual lineages.
It is important to mention that current epigenetic studies are
based on a snapshot analysis of cells within heterogeneous
populations. Thus, the interpretation of current data may be
compromised by the noise as a result of heterogeneity. The
current epigenetic viewalso fails to reveal the dynamic chromatin
changes that occur during effector T cell differentiation. Long-
range inter- and intrachromosomal interactions of cytokine
gene loci regulate T helper cell differentiation (Rowell et al.,
2008). It will be informative to analyze these interactions during
redifferentiation of T helper cells as well. Lineage-restricted
transcription factors play critical roles in epigenetic regulation
of cytokine gene expression, such as initiation of chromatin
remodeling and maintenance of chromatin structure. However,
the mechanisms underlying epigenetic regulation (including heri-
table changes in expression of target genes) by these factors are
largely unknown. Understanding themechanisms bywhich biva-
lent modifications at the transcription factor loci are achieved will
help to delineate T helper cell lineage commitment and plasticity.
Finally, it is important to mention that most of the current
studies showing the plasticity of T helper cell differentiation
program are performed at the population level. Therefore, purity
of the population has to be assured by vigorous cell sorting to
avoid potential contaminants. Lineage-specific transcription
factor or cytokine reporter mouse models have been invaluable
tools to study T helper cell differentiation and will continue to
provide a better understanding of T helper cell plasticity, which
should be ideally evaluated at the single-cell level. Identification
of in vitro culture conditions that mimic in vivo environments will
allow us to dissect the signaling pathways and the transcriptional
regulatory networks of the T helper cell differentiation program.
Conclusions
T helper cell lineage commitment was originally viewed as
a unidirectional process with nonreversible terminal differentia-
tion of Th1 and Th2 cells. Each T helper cell subset expresses
its lineage-specific transcription factors and mutually exclusive
cytokines. The discovery of two new subsets of T helper cells,
Treg cells and Th17 cells, and their capacity to produce cyto-
kines that would be considered hallmarks of opposing lineages
suggest that the commitment of T helper cell lineages is more
plastic than previously appreciated. Epigenetic modifications
of cytokine genes and key transcriptional regulator genes direct
the T helper cell differentiation program. The flexibility of Treg
and Th17 cell differentiation may provide us with amodel system652 Immunity 30, May 22, 2009 ª2009 Elsevier Inc.to study the contributions of reversible and dynamic chromatin
changes in T cell development. The plasticity and unstable
phenotypes of Tregs and Th17 cells will have important biolog-
ical implications for designing therapeutic regimens to combat
infections and control autoimmunity.
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